 |
Danese Silvio; Colombel Jean-Frederic; Lukas Milan; Gisbert Javier P; D'Haens Geert; Hayee Bu'hussain; Panaccione Remo; Kim Hyun-Soo; Reinisch Walter; Tyrrell Helen; Oh Young S; Tole Swati; Chai Akiko; Chamberlain-James Kirsten; Tang Meina Tao; Schreiber Stefan; Fejes Roland; Gyökeres Tibor Zoltán; Molnár Tamás; et al.:
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA) : a randomised, double-blind, double-dummy, phase 3 study.
LANCET GASTROENTEROLOGY AND HEPATOLOGY, 7 (2).
pp. 118-127.
ISSN 2468-1253
(2022)
Sands Bruce E.; Peyrin-Biroulet Laurent; Loftus Edward V.; Danese Silvio; Colombel Jean-Frederic; Törüner Murat; Jonaitis Laimas; Abhyankar Brihad; Rogers Raquel; Chen Jingjing; Lirio Richard A.; Bornstein Jeffrey D.; VARSITY Study Group; Altorjay István; Molnár Tamás:
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
NEW ENGLAND JOURNAL OF MEDICINE, 381 (13).
pp. 1215-1226.
ISSN 0028-4793
(2019)
![[Fel]](/style/images/multi_up.png)
Vissza
